THERYCELL

TheryCell was founded in late 2017 by a small team of people bringing together expertise in T-cell analysis, bioinformatics, sequencing, molecular biology technologies, as well as business and management experiences in biotech start-ups and big pharma companies... At TheryCell we are developing a new approach to learn from a patients own T-cells how to direct them against his/her individual cancer. It is our strong belief that following these lines we can implement a new kind of personalized immunotherapy for solid tumors with improved efficacy and safety... The principles of our technology are patent protected and tested in dozens of tumor samples. We are currently active in several cooperations with clinics and research institutes to promote our concept and to prove the tumor killing potential of our dedicated T-cell selections

Also known as: TheryCell GmbH

Primary location: Berlin